期刊文献+

老年危重病患者院内获得性耐碳青霉烯类肺炎克雷伯菌血流感染预后的相关因素 被引量:15

Related risk factors for the prognosis of hospital-acquired carbapenem-resistant Klebsiella pneumoniae bloodstream infections in elderly patients with critical illness
原文传递
导出
摘要 目的探讨影响院内获得性耐碳氢酶烯类肺炎克雷伯菌(carbapenem-resistant Klebsiella pneumoniae CRKP)血流感染的老年危重病患者预后的相关因素。方法回顾性分析2010年1月至2016年12月我院重症医学科(ICU)内院内获得性CRKP血流感染的老年危重病患者的临床资料,根据预后分为死亡组和生存组,比较两组患者的临床特点,采用Logistic回归筛选影响ICU内院内获得性CRKP血流感染老年危重病患者预后的相关因素。结果共纳入119例CRKP血流感染老年危重病患者,ICU内病死率为62.2%(74/119),使用替加环素治疗者病死率较未使用替加环素者病死率低[50.0%(25/50)比71.0%(49/69),χ^2=4.770,P=0.029];联合抗菌药物治疗较单药治疗病死率低[54.9%(39/71)比72.9%(35/48),χ^2=3.940,P=0.047)]。多因素Logistic回归分析结果显示,使用血管活性药物(OR=25.545,95%CI:9.743~52.242,P=0.001)、替加环素药敏为耐药(OR=8.990,95%CI:0.957~24.488,P=0.049)是死亡的独立危险因素,进行合适的初始治疗(定义为48 h内至少采用1种敏感抗生素治疗,OR=0.081,95%CI:0.014~0.463,P=0.005)及足够的合适抗生素治疗疗程(OR=0.785,95%CI:0.631~0.977,P=0.030)是改善预后的保护因素。结论ICU内获得性CRKP血流感染的老年患者病死率高,合适的初始治疗及足够的疗程能明显降低死亡风险。 Objective To investigate the related risk factors for the prognosis of hospital-acquired carbapenem-resistant Klebsiella pneumoniae(CRKP)bloodstream infections in elderly patients with critical illness.Methods Clinical data of elderly patients with nosocomial CRKP bloodstream infection in intensive care unit(ICU)from Jan.2010 to Dec.2016 were retrospectively analyzed.Patients were divided into the death and survival groups according to the prognosis.Clinical characteristics were compared between the two groups.Influencing factors for the prognosis of nosocomial CRKP bloodstream infections in elderly ICU patients were screened by multivariate Logistic regression analysis.Results A total of 119 elderly ICU patients with nosocomial CRKP bloodstream infection were enrolled.The overall ICU mortality rate was 62.2%(74/119 patients),among which the ICU mortality was lower in patients treated with tigecycline than without tigecycline treatment(50.0%or 25/50 vs.71.0%or 49/69,χ^2=4.770,P=0.029).And the ICU mortality was lower in patients with combination therapy than with mono-therapy(54.9%or 39/71 vs.72.9%or 35/48,χ^2=3.940,P=0.047).Multivariate Logistic regression analysis revealed that the administration of vasoactive drugs(OR=25.545,95%CI:9.743-52.242,P=0.001),and the resistance to tigecycline(OR=8.990,95%CI:0.957-24.488,P=0.049)were independent risk factors for ICU mortality.While the early initiated appropriate antibiotics treatment,which was defined as using at least one susceptible antibiotic within 48 hours(OR=0.081,95%CI:0.014-0.463,P=0.005),and appropriate antibiotics and adequate duration(OR=0.785,95%CI:0.631-0.977,P=0.030),were protective factors for the good outcome.Conclusions Nosocomial CRKP bloodstream infection in elderly ICU patients leads a high ICU mortality rate.The early initiated appropriate antibiotics treatment and optimum antibiotics duration could reduce the risk for death.
作者 杨向红 何方 吕智全 洪军 陈敏华 孙仁华 Yang Xianghong;He Fang;Lyu Zhiquan;Hong Jun;Chen Minhua;Sun Renhua(Intensive Care Unit,Zhejiang Provincial People’s Hospital,People’s Hospital of Hangzhou Medical College,Hangzhou 310014,China;Department of Clinical Laboratory,Zhejiang Provincial People’s Hospital,People’s Hospital of Hangzhou Medical College,Hangzhou 310014,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2020年第5期530-534,共5页 Chinese Journal of Geriatrics
基金 国家自然青年科学基金项目(81702042)。
关键词 肺炎 克雷伯菌感染 预后 危险因素 Pneumonia Klebsiella infections Prognosis Risk factors
  • 相关文献

参考文献4

二级参考文献32

  • 1Clinical and Laboratory Standards Institute.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;Approved standard-ninth edition.CLSI document M07-A9[EB/OL].Wayne,PA:CLSI,2012. 被引量:1
  • 2Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing;Twenty-third informational supplement.CLSI document M100-S23[EB/OL].Wayne,PA:CLSI,2013. 被引量:1
  • 3Borer A,Saidel-Odes L,Riesenberg K,et al.Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia[J].Infect Control Hosp Epidemiol,2009,30 (10):972-976. 被引量:1
  • 4Schwaber MJ,Klarfeld-Lidji S,Navon-Venezia S,et al.Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality[J].Antimicrob Agents Chemother,2008,52 (3):1028-1033. 被引量:1
  • 5Yang Q,Wang H,Sun H,et al.Phenotypic and Genotypic Characterization of Enterobacteriaceae with Decreased Susceptibility to Carbapenems:Results from Large Hospital-Based Surveillance Studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577. 被引量:1
  • 6Sun W,Chen H,Liu Y,et al.Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China[J].Antimicrob Agents Chemother,2009,53(9):3642-3649. 被引量:1
  • 7Yahav D,Lador A,Paul M,et al.Efficacy and safety of tigecycline:a systematic review and meta-analysis[J].J Antimicrob Chemother,2011,66 (9):1963-1971. 被引量:1
  • 8Lee YT,Tsao SM,Hsueh PR.Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections[J].Eur J Clin Microbiol Infect Dis,2013,32(9):1211-1220. 被引量:1
  • 9Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing [S].Twenty- Fourth Informational Supplement,2014,M100-S24. 被引量:1
  • 10Pifzer Inc.Tygacil? Product Insert.Philadelphia,PA,2013[Z/OL].[2015-04-201.http://www.pfizerpro.com/hcp/tygacil. 被引量:1

共引文献6370

同被引文献162

引证文献15

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部